Follett Ice Machines Named Best In Class by Foodservice Consultants

FollettFollett ice machines have been named Best in Class by foodservice consultants in a study conducted by Foodservice Equipment and Supplies in partnership with an international research firm. The results were announced in the magazine's October 2011 issue.

Products were evaluated by subscribing foodservice consultants widely considered experts in the industry, based on seven critical performance factors that impacted their purchase or specification decisions: product quality, product value, product design and aesthetics, service and support, sales representation, product inventory and availability and product information availability.

Follett ice machines produce consumer-preferred* Chewblet ice and feature Follett's exclusive Satellite-fill technology, which delivers ice through a tube to a dispenser or storage bin up to 75 feet away from the ice machine.

Founded in 1948, Follett Corporation is a leading manufacturer of ice-related equipment, including ice machines, ice storage and transport equipment, ice and beverage and ice and water dispensing equipment for foodservice and healthcare markets worldwide.

Foodservice Equipment and Supplies delivers first-hand research and content regarding the trends and topics of concern to equipment and supplies professionals in print, online and in person. It reaches over 23,000 magazine subscribers and over 50,000 email newsletter subscribers.

For more information, contact Follett Corporation at 610-252-7301, or visit

*Based on an independent consumer study conducted by Roper ASW. Contact Follett for details. Follett and Chewblet are registered trademarks of Follett Corporation, registered in the United States. Satellite-fill is a trademark of Follett Corporation.


Suggested Articles

A breakdown of the latest $1 trillion from the Senate.

The number of businesses switching from temporary to permanent closures surpasses 50%.

The coronavirus continues to threaten our industry but there are promising medical developments and still many questions on the next round of relief.